Suppr超能文献

肝硬化对急性呼吸衰竭后长期预后的影响:一项基于人群的研究。

Effect of liver cirrhosis on long-term outcomes after acute respiratory failure: A population-based study.

作者信息

Lai Chih-Cheng, Ho Chung-Han, Cheng Kuo-Chen, Chao Chien-Ming, Chen Chin-Ming, Chou Willy

机构信息

Chih-Cheng Lai, Chien-Ming Chao, Department of Intensive Care Medicine, Chi Mei Medical Center, Liouying, Tainan 736, Taiwan.

出版信息

World J Gastroenterol. 2017 Mar 28;23(12):2201-2208. doi: 10.3748/wjg.v23.i12.2201.

Abstract

AIM

To assessed the effect of liver cirrhosis (LC) on the poorly understood long-term mortality risk after first-ever mechanical ventilation (1-MV) for acute respiratory failure.

METHODS

All patients in Taiwan given a 1-MV between 1997 and 2013 were identified in Taiwan's Longitudinal Health Insurance Database 2000. Each patient with LC was individually matched, using a propensity-score method, to two patients without LC. The primary outcome was death after a 1-MV.

RESULTS

A total of 16653 patients were enrolled: 5551 LC-positive (LC) patients, including 1732 with cryptogenic LCs and 11102 LC-negative (LC) controls. LC patients had more organ failures and were more likely to be admitted to medical department than were LC controls. LC patients had a significantly lower survival rate (AHR = 1.38, 95%CI: 1.32-1.44). Moreover, the mortality risk was significantly higher for patients with non-cryptogenic LC than for patients with cryptogenic LC (AHR = 1.43, 95%CI: 1.32-1.54) and patients without LC (AHR = 1.56, 95%CI: 1.32-1.54). However, there was no significant difference between patients with cryptogenic and without LC (HR = 1.05, 95%CI: 0.98-1.12).

CONCLUSION

LC, especially non-cryptogenic LC, significantly increases the risk of death after a 1-MV.

摘要

目的

评估肝硬化(LC)对首次因急性呼吸衰竭进行机械通气(1-MV)后尚未被充分了解的长期死亡风险的影响。

方法

在台湾2000年纵向健康保险数据库中识别出1997年至2013年间接受1-MV的所有台湾患者。使用倾向评分法将每位LC患者与两名无LC的患者进行个体匹配。主要结局是1-MV后的死亡。

结果

共纳入16653例患者:5551例LC阳性(LC)患者,包括1732例隐源性LC患者和11102例LC阴性(LC)对照。与LC对照相比,LC患者有更多器官功能衰竭,且更有可能入住内科。LC患者的生存率显著较低(风险比=1.38,95%置信区间:1.32-1.44)。此外,非隐源性LC患者的死亡风险显著高于隐源性LC患者(风险比=1.43,95%置信区间:1.32-1.54)和无LC患者(风险比=1.56,95%置信区间:1.32-1.54)。然而,隐源性LC患者和无LC患者之间无显著差异(风险比=1.05,95%置信区间:0.98-1.12)。

结论

LC,尤其是非隐源性LC,显著增加1-MV后的死亡风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e241/5374132/bf6a7189e9d5/WJG-23-2201-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验